NCT00223158View on ClinicalTrials.gov

Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Thyroid Cancer
Interventions
DRUG

Liothyronine

Trial Locations (1)

J1H 5N4

Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke

All Listed Sponsors
collaborator

Theramed co.

UNKNOWN

lead

Patrice Perron

OTHER

NCT00223158 - Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer | Biotech Hunter | Biotech Hunter